December 15, 2016
Results of filgotinib Gilead’s study in Chron’s
Galapagos has tested its filgotinib – JAK1 inhibitor – in a phase 2 study, for the patients with Chron’s disease, and…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Galapagos